Zanatta E, Colombo C, D’Amico G, d’Humières T, Dal Lin C, Tona F (2019) Inflammation and Coronary Microvascular Dysfunction in Autoimmune Rheumatic Diseases. Int J Mol Sci 20(22):5563. https://doi.org/10.3390/ijms20225563

CAS  Article  PubMed Central  Google Scholar 

Ferri C, Manfredi A, Sebastiani M, Colaci M, Giuggioli D, Vacchi C, Della Casa G, Cerri S, Torricelli P, Luppi F (2016) Interstitial pneumonia with autoimmune features and undifferentiated connective tissue disease: Our interdisciplinary rheumatology-pneumology experience, and review of the literature. Autoimmun Rev 15(1):61–70. https://doi.org/10.1016/j.autrev.2015.09.003

CAS  Article  PubMed  Google Scholar 

Spagnolo P, Lee JS, Sverzellati N, Rossi G, Cottin V (2018) The Lung in Rheumatoid Arthritis: Focus on Interstitial Lung Disease. Arthritis Rheumatol 70(10):1544–1554. https://doi.org/10.1002/art.40574

Article  PubMed  Google Scholar 

Aguilera-Pickens G, Abud-Mendoza C (2018) Pulmonary manifestations in systemic lupus erythematosus: pleural involvement, acute pneumonitis, chronic interstitial lung disease and diffuse alveolar hemorrhage. Reumatol Clin (Engl Ed) 14(5):294–300. https://doi.org/10.1016/j.reuma.2018.03.012

Article  Google Scholar 

Balbir-Gurman A, Yigla M, Nahir AM, Braun-Moscovici Y (2006) Rheumatoid pleural effusion. Semin Arthritis Rheum 35(6):368–378. https://doi.org/10.1016/j.semarthrit.2006.03.002

Article  PubMed  Google Scholar 

Bouros D, Pneumatikos I, Tzouvelekis A (2008) Pleural involvement in systemic autoimmune disorders. Respiration 75(4):361–371. https://doi.org/10.1159/000119051

Article  PubMed  Google Scholar 

Ha YJ, Lee YJ, Kang EH (2018) Lung Involvements in Rheumatic Diseases: Update on the Epidemiology, Pathogenesis, Clinical Features, and Treatment. Biomed Res Int 2018:6930297. https://doi.org/10.1155/2018/6930297

CAS  Article  PubMed  PubMed Central  Google Scholar 

Zanatta E, Polito P, Famoso G, Larosa M, De Zorzi E, Scarpieri E, Cozzi F, Doria A (2019) Pulmonary arterial hypertension in connective tissue disorders: Pathophysiology and treatment. Exp Biol Med (Maywood) 244(2):120–131. https://doi.org/10.1177/1535370218824101

CAS  Article  Google Scholar 

Hughes M, Zanatta E, Sandler RD, Avouac J, Allanore Y (2021) Improvement with time of vascular outcomes in systemic sclerosis: a systematic review and meta-analysis study. Rheumatology (Oxford). https://doi.org/10.1093/rheumatology/keab850

Article  PubMed Central  Google Scholar 

Tyndall AJ, Bannert B, Vonk M et al (2010) Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database. Ann Rheum Dis 69(10):1809–1815. https://doi.org/10.1136/ard.2009.114264

Article  PubMed  Google Scholar 

Flaherty KR, Wells AU, Cottin V et al (2019) Nintedanib in Progressive Fibrosing Interstitial Lung Diseases. N Engl J Med 381(18):1718–1727. https://doi.org/10.1056/NEJMoa1908681

CAS  Article  PubMed  Google Scholar 

Cottin V, Brown KK (2019) Interstitial lung disease associated with systemic sclerosis (SSc-ILD). Respir Res 20(1):13. https://doi.org/10.1186/s12931-019-0980-7

Article  PubMed  PubMed Central  Google Scholar 

Hoffmann-Vold A-M, Maher TM, Philpot EE et al (2020) The identification and management of interstitial lung disease in systemic sclerosis: evidence-based European consensus statements. Lancet Rheumatol 2(2):71–83. https://doi.org/10.1016/S2665-9913(19)30144-4

Article  Google Scholar 

Zanatta E, Martini A, Scarpieri E, Biasiolo A, Ortolan A, Benvenuti F, Cozzi F, Pontisso P, Doria A (2020) Squamous cell carcinoma antigen-IgM (SCCA-IgM) is associated with interstitial lung disease in systemic sclerosis. Joint Bone Spine 87(4):331–335. https://doi.org/10.1016/j.jbspin.2020.02.003

CAS  Article  PubMed  Google Scholar 

Elhai M, Hoffmann-Vold AM, Avouac J et al (2019) Performance of Candidate Serum Biomarkers for Systemic Sclerosis-Associated Interstitial Lung Disease. Arthritis Rheumatol 71(6):972–982. https://doi.org/10.1002/art.40815

CAS  Article  PubMed  Google Scholar 

Allanore Y, Simms R, Distler O, Trojanowska M, Pope J, Denton CP, Varga J (2015) Systemic sclerosis. Nat Rev Dis Prim 1:15002. https://doi.org/10.1038/nrdp.2015.2

Article  PubMed  Google Scholar 

Frantz C, Auffray C, Avouac J, Allanore Y (2018) Regulatory T cells in systemic sclerosis. Front Immunol 9:2356. https://doi.org/10.3389/fimmu.2018.02356

CAS  Article  PubMed  PubMed Central  Google Scholar 

Odaka M, Hasegawa M, Hamaguchi Y, Ishiura N, Kumada S, Matsushita T, Komura K, Sato S, Takehara K, Fujimoto M (2010) Autoantibody-mediated regulation of B cell responses by functional anti-CD22 autoantibodies in patients with systemic sclerosis. Clin Exp Immunol 159(2):176–184. https://doi.org/10.1111/j.1365-2249.2009.04059.x

CAS  Article  PubMed  PubMed Central  Google Scholar 

Sato S, Fujimoto M, Hasegawa M, Takehara K (2004) Altered blood B lymphocyte homeostasis in systemic sclerosis: Expanded naive B cells and diminished but activated memory B cells. Arthritis Rheum 50(6):1918–1927. https://doi.org/10.1002/art.20274

Article  PubMed  Google Scholar 

Sakkas LI, Bogdanos DP (2016) Systemic sclerosis: New evidence re-enforces the role of B cells. Autoimmun Rev 15(2):155–161. https://doi.org/10.1016/j.autrev.2015.10.005

CAS  Article  PubMed  Google Scholar 

Yoshizaki A (2018) Pathogenic roles of B lymphocytes in systemic sclerosis. Immunol Lett 195:76–82. https://doi.org/10.1016/j.imlet.2018.01.002

CAS  Article  PubMed  Google Scholar 

Sakkas LI, Platsoucas CD (2004) Is systemic sclerosis an antigen-driven T cell disease? Arthritis Rheum 50(6):1721–1733. https://doi.org/10.1002/art.20315

CAS  Article  PubMed  Google Scholar 

Mo C, Zeng Z, Deng Q, Ding Y, Xiao R (2018) Imbalance between T helper 17 and regulatory T cell subsets plays a significant role in the pathogenesis of systemic sclerosis. Biomed Pharmacother 108:177–183. https://doi.org/10.1016/j.biopha.2018.09.037

CAS  Article  PubMed  Google Scholar 

Soldano S, Trombetta AC, Contini P, Tomatis V, Ruaro B, Brizzolara R, Montagna P, Sulli A, Paolino S, Pizzorni C, Smith V, Cutolo M (2018) Increase in circulating cells coexpressing M1 and M2 macrophage surface markers in patients with systemic sclerosis. Ann Rheum Dis 77(12):1842–1845. https://doi.org/10.1136/annrheumdis-2018-213648

CAS  Article  PubMed  Google Scholar 

Soldano S, Trombetta AC, Contini P, Tomatis V, Ruaro B, Brizzolara R, Montagna P, Sulli A, Paolino S, Pizzorni C, Smith V, Cutolo M (2018) A circulating cell population showing both M1 and M2 monocyte/macrophage surface markers characterizes systemic sclerosis patients with lung involvement. Respir Res 19(1):186. https://doi.org/10.1186/s12931-018-0891-z

CAS  Article  PubMed  PubMed Central  Google Scholar 

Ruano CA, Lucas RN, Leal CI, Lourenço J, Pinheiro S, Fernandes O, Figueiredo L (2015) Thoracic Manifestations of Connective Tissue Diseases. Vol. 44. Curr Prob Diagnos Radiol 44(1):47–59. https://doi.org/10.1067/j.cpradiol.2014.07.002

Behr J, Furst DE (2008) Pulmonary function tests. Rheumatology (Oxford) 47(Suppl 5): v 65–7. https://doi.org/10.1093/rheumatology/ken313.

Demoruelle MK, Mittoo S, Solomon JJ (2016) Connective tissue disease-related interstitial lung disease. Best Pract Res Clin Rheumatol 30(1):39–52. https://doi.org/10.1016/j.berh.2016.04.006

Article  PubMed  Google Scholar 

Steen VD, Conte C, Owens GR, Medsger TA Jr (1994) Severe restrictive lung disease in systemic sclerosis. Arthritis Rheum 37(9):1283–1289. https://doi.org/10.1002/art.1780370903

CAS  Article  PubMed  Google Scholar 

Schurawitzki H, Stiglbauer R, Graninger W, Herold C, Pölzleitner D, Burghuber OC, Tscholakoff D (1990) Interstitial lung disease in progressive systemic sclerosis: high-resolution CT versus radiography. Radiology 176(3):755–759. https://doi.org/10.1148/radiology.176.3.2389033

CAS  Article  PubMed  Google Scholar 

Wu W, Jordan S, Becker MO, Dobrota R, Maurer B, Fretheim H, Ye S, Siegert E, Allanore Y, Hoffmann-Vold AM, Distler O (2018) Prediction of progression of interstitial lung disease in patients with systemic sclerosis: the SPAR model. Ann Rheum Dis 77:1326–1332. https://doi.org/10.1136/annrheumdis-2018-213201

CAS  Article  PubMed  Google Scholar 

Winstone TA, Assayag D, Wilcox PG, Dunne JV, Hague CJ, Leipsic J, Collard HR, Ryerson CJ (2014) Predictors of Mortality and Progression in Scleroderma-Associated Interstitial Lung Disease. Chest 146(2):422–436. https://doi.org/10.1378/chest.13-2626

Article  PubMed  Google Scholar 

Cappelli S, Bellando Randone S, Camiciottoli G, De Paulis A, Guiducci S, Matucci-Cerinic M (2015) Interstitial lung disease in systemic sclerosis: where do we stand? Eur Respir Rev 24(137):411–419. https://doi.org/10.1183/16000617.00002915

Article  PubMed  Google Scholar 

Yang JA, Lee JS, Park JK, Lee EB, Song YW, Lee EY (2019) Clinical characteristics associated with occurrence and poor prognosis of interstitial lung disease in rheumatoid arthritis. Korean J Intern Med 34(2):434–441. https://doi.org/10.3904/kjim.2016.349

Article  PubMed  Google Scholar 

Li L, Liu R, Zhang Y, Zhou J, Li Y, Xu Y, Gao S, Zheng Y (2020) A retrospective study on the predictive implications of clinical characteristics and therapeutic management in patients with rheumatoid arthritis-associated interstitial lung disease. Clin Rheumatol 39(5):1457–1470. https://doi.org/10.1007/s10067-019-04846-1

Article  PubMed  Google Scholar 

Qiu M, Jiang J, Nian X, Wang Y, Yu P, Song J, Zou S (2021) Factors associated with mortality in rheumatoid arthritis-associated interstitial lung disease: a systematic review and meta-analysis. Respir Res 22(1):264. https://doi.org/10.1186/s12931-021-01856-z

Article  PubMed  PubMed Central  Google Scholar 

Catrina AI, Ytterberg AJ, Reynisdottir G, Malmström V, Klareskog L (2014) Lungs, joints and immunity against citrullinated proteins in rheumatoid arthritis. Nat Rev Rheumatol 10(11): 645–53. https://doi.org/10.1038/nrrheum.2014.115

Johnson C (2017) Recent advances in the pathogenesis, prediction, and management of rheumatoid arthritis-associated interstitial lung disease. Curr Opin Rheumatol 29(3):254–259. https://doi.org/10.1097/BOR.0000000000000380

Article  PubMed  Google Scholar 

Wang D, Zhang J, Lau J, Wang S, Taneja V, Matteson EL, Vassallo R (2019) Mechanisms of lung disease development in rheumatoid arthritis. Nat Rev Rheumatol 15(10):581–596. https://doi.org/10.1038/s41584-019-0275-

Article  PubMed  Google Scholar 

Willis VC, Demoruelle MK, Derber LA, Chartier-Logan CJ, Parish MC, Pedraza IF, Weisman MH, Norris JM, Holers VM, Deane KD (2013) Sputum autoantibodies in patients with established rheumatoid arthritis and subjects at risk of future clinically apparent disease. Arthritis Rheum 65(10):2545–2554. https://doi.org/10.1002/art.38066

CAS  Article  PubMed  PubMed Central